› 6opj

X-ray diffraction
1.5Å resolution

Menin in complex with peptide inhibitor 25

Released:
DOI: 10.2210/pdb6opj/pdb
Model geometry
Fit model/data
PDB entry 6opj coloured by chain, front view.
PDB entry 6opj coloured by chain, side view.
PDB entry 6opj coloured by chain, top view.
Source organism: Homo sapiens
Primary publication:
Covalent and noncovalent constraints yield a figure eight-like conformation of a peptide inhibiting the menin-MLL interaction.
Fortuna P, Linhares BM, Purohit T, Pollock J, Cierpicki T, Grembecka J, Berlicki Ł
Eur J Med Chem 207 112748 (2020)
PMID: 32882610

Function and Biology Details

Biochemical function:
  • not assigned
Biological process:
  • not assigned
Cellular component:
Sequence domain:

Structure analysis Details

Assembly composition:
hetero dimer (preferred)
Assembly name:
PDBe Complex ID:
PDB-CPX-126202 (preferred)
Entry contents:
2 distinct polypeptide molecules
Macromolecules (2 distinct):
Menin Chain: A
Molecule details ›
Chain: A
Length: 489 amino acids
Theoretical weight: 54.57 KDa
Source organism: Homo sapiens
Expression system: Escherichia coli
UniProt:
  • Canonical: O00255 (Residues: 1-593; Coverage: 79%)
  • Best match: O00255-1 (Residues: 1-598)
Gene names: MEN1, SCG2
Sequence domains: Menin
Peptide inhibitor 25 Chain: B
Molecule details ›
Chain: B
Length: 13 amino acids
Theoretical weight: 1.51 KDa
Source organism: Homo sapiens
Expression system: Not provided

Ligands and Environments

3 bound ligands:
Ligand DMS 4 x DMS
Ligand SO4 3 x SO4
Ligand PG4 1 x PG4
3 modified residues:
Ligand ABA 2 x ABA
Ligand N0A 1 x N0A
Ligand ORN 1 x ORN

Experiments and Validation Details

wwPDB Validation report is not available for this entry.
X-ray source: APS BEAMLINE 21-ID-G
Spacegroup: P212121
Unit cell:
a: 47.867Å b: 78.145Å c: 123.702Å
α: 90° β: 90° γ: 90°
R-values:
R R work R free
0.17 0.168 0.197
Expression systems:
  • Escherichia coli
  • Not provided

Quick links

Citations

1 review citation

Structure, function and inhibition of critical protein-protein interactions involving mixed lineage leukemia 1 and its fusion oncoproteins.
Li et al. (2021)